Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Borderline Personality Disorder01:25

Borderline Personality Disorder

138
Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...
138
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

201
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
201
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

437
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
437
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

314
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
314
Drug Therapy01:28

Drug Therapy

92
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
92
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

212
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
212

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-reported outcomes for monitoring substance use treatment: A systematic review of single-item measures.

Addiction (Abingdon, England)·2026
Same author

A Treatment Selection Model for Opioid Use Disorder Using Electronic Health Record and ZIP-Level Data.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same author

Addiction care outcomes between insured and state opioid response grant-funded patients in a Medicaid non-expansion state.

Journal of substance use and addiction treatment·2026
Same author

Correction: Update on Psychiatry Residency Training in Personality Disorders: Becoming a Good Psychiatrist Through Becoming "Good Enough" at Treating Borderline and Narcissistic Personality Disorders.

Current psychiatry reports·2025
Same author

Clinician Perspectives on a Predictive Model for Recommending Opioid Use Disorder Treatment.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2025
Same author

The 24-year course of substance use disorders in patients with borderline personality disorder and personality-disordered comparison subjects.

The American journal on addictions·2025

Related Experiment Video

Updated: Aug 31, 2025

Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder
09:55

Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder

Published on: March 8, 2018

12.6K

C-L Case Conference: Applying Good Psychiatric Management for Borderline Personality Disorder in Hospitalized

Barrington J Hwang1, Brandon T Unruh2, Kristopher A Kast1

  • 1Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN.

Journal of the Academy of Consultation-Liaison Psychiatry
|August 22, 2022
PubMed
Summary

Managing comorbid borderline personality disorder and substance use disorders presents challenges in hospitals. This case study offers strategies for patient-centered care, including diagnosis, pharmacologic management, and team dynamics.

Keywords:
alcohol use disorderbehavior planningborderline personality disordergood psychiatric managementopioid use disordersubstance use disorder

More Related Videos

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.8K

Related Experiment Videos

Last Updated: Aug 31, 2025

Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder
09:55

Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder

Published on: March 8, 2018

12.6K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.8K

Area of Science:

  • Psychiatry
  • Addiction Medicine

Background:

  • Comorbid borderline personality disorder (BPD) and substance use disorders (SUDs) pose significant management challenges in hospital settings.
  • Effective treatment requires a multidisciplinary approach addressing both psychiatric and addiction components.

Observation:

  • This case illustrates common difficulties encountered in the hospital management and treatment of patients with co-occurring BPD and SUDs.
  • Expert discussions highlight patient-centered strategies tailored for this complex population.

Findings:

  • Key learning points encompass BPD evaluation and diagnosis, principles of good psychiatric management, and withdrawal/pharmacologic strategies.
  • Harm reduction, team dynamics, and behavioral planning are crucial elements for successful inpatient care.
  • Actionable considerations are provided for clinical encounters common in general hospital settings.

Implications:

  • This paper offers practical guidance for consultation-liaison psychiatrists and healthcare teams managing complex comorbid conditions.
  • Improved understanding and application of these strategies can enhance patient outcomes and hospital treatment efficacy.
  • The insights are applicable to a wide range of clinical scenarios involving BPD and SUDs.